ProQR Therapeutics N.V. (PRQR)
Nasdaq: PRQR · Pharmaceutical Preparations · Leiden, NL · filing with the SEC since 2014
Who runs ProQR Therapeutics N.V.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
De Boer Daniel Anton
Chief Executive Officer. First filing Mar 2026, latest Aug 3, 2026, 3 filings in all.
Officers reporting now
3
of 11 people with a filing in the last fifteen months
Directors reporting now
8
11 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| De Boer Daniel Anton | Chief Executive Officer | Mar 2026 | Aug 3, 2026 | none |
| Hom Dennis | Chief Financial Officer | Mar 2026 | Mar 18, 2026 | none |
| Platenburg Gerardus Johannes | Chief Scientific Officer | Mar 2026 | Mar 18, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Filius Bart | director | Mar 2026 | Jul 21, 2026 | none |
| Hinsch Gylvin Lykke | director | Jun 2026 | Jun 30, 2026 | none |
| Carreno-Gomez Begona | director | Mar 2026 | Mar 18, 2026 | none |
| Heggie Theresa | director | Mar 2026 | Mar 18, 2026 | none |
| Lawton Alison Frances | director | Mar 2026 | Mar 18, 2026 | none |
| Maier Martin Alexander | director | Mar 2026 | Mar 18, 2026 | none |
| Shannon James Samuel | director | Mar 2026 | Mar 18, 2026 | none |
| Valerio Domenico | director | Mar 2026 | Mar 18, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.